Enter your patient's systolic blood pressure, heart rate, respiratory rate, temperature, urine output, and AVPU neurological score to calculate their Modified Early Warning Score (MEWS). You'll get the total MEWS score along with a clinical risk interpretation to help identify patients requiring escalated care or ICU admission.
MEWS Score
--
Risk Category
--
Clinical Recommendation
--
The MEWS is a clinical scoring system that uses five physiological parameters — systolic blood pressure, heart rate, respiratory rate, temperature, and level of consciousness (AVPU) — plus urine output to assess how unwell a patient is. It helps healthcare providers identify patients at risk of rapid deterioration who may need a higher level of care, such as ICU admission.
A MEWS score of 5 or more is associated with a significantly increased likelihood of death or admission to an intensive care unit (ICU) or high dependency unit (HDU). Scores of 0–1 are considered low risk, 2–4 indicate moderate risk requiring closer monitoring, and 5 or above signal a critical situation requiring urgent clinical intervention.
Each of the six parameters (systolic BP, heart rate, respiratory rate, temperature, urine output, and AVPU) is assigned a score of 0–3 depending on how far the measured value deviates from normal. The individual scores are summed to produce the total MEWS score. Higher deviations from normal physiology result in higher scores.
AVPU stands for Alert, Voice, Pain, and Unresponsive. It is a simple neurological assessment: Alert (0 points) means the patient is fully awake; Voice (1 point) means they respond to verbal stimuli; Pain (2 points) means they only respond to painful stimuli; Unresponsive (3 points) means no response to any stimuli.
The MEWS tool is designed for use by any trained medical provider, including nurses, doctors, paramedics, and allied health professionals. Many hospitals have incorporated MEWS into nursing protocols to standardize early warning and escalation procedures at the bedside.
A MEWS score of 0–1 is generally considered low risk and indicates stable physiological parameters. A score of 2–4 suggests the patient should be monitored more closely, while a score of 5 or higher warrants immediate clinical review and possible transfer to a higher level of care.
Yes. The MEWS score can be applied to patients hospitalized due to COVID-19, surgical conditions, or any other serious medical illness. It provides a rapid assessment of mortality risk and helps flag patients who need increased medical attention, regardless of the underlying diagnosis.
The original EWS was developed in the late 1990s to track in-hospital patient deterioration. MEWS is a modified version designed to cover a broader range of patients and clinical situations. Key additions in MEWS include the AVPU neurological assessment and urine output, making it more comprehensive than the original EWS.